Patient Name : Mrs.
SUJATHA V Collected : 01/Sep/2025 10:37AM
Age/Gender : 28 Y 11 M 13 D/F Received : 01/Sep/2025 11:16AM
UHID/MR No : RELE.0000001413 Reported : 01/Sep/2025 12:13PM
Visit ID : RELEOPV7811 Status : Final Report
Ref Doctor : Dr.Dr RITU CHOUDHARY
DEPARTMENT OF IMMUNOLOGY
Test Name Result Unit Bio. Ref. Interval Method
THYROID PROFILE TOTAL (T3, T4, TSH) , SERUM
TRI-IODOTHYRONINE (T3, TOTAL) 145.3 ng/dL 84.6-202 ECLIA
THYROXINE (T4, TOTAL) 10.29 µg/dL 5.12-14.06 ECLIA
TSH (Ultrasensitive/4thGen) 2.740 µIU/mL 0.270-4.20 ECLIA
Comment:
For Pregnant Women Bio Ref Range for TSH in µIU/mL
First trimester 0.33 – 4.59
Second trimester 0.35 – 4.10
Third trimester 0.21 – 3.15
1. TSH is a glycoprotein hormone secreted by the anterior pituitary. TSH activates production of T3 (Triiodothyronine) and its
prohormone T4 (Thyroxine). Increased blood level of T3 and T4 inhibit production of TSH.
2. TSH is elevated in primary hypothyroidism and will be low in primary hyperthyroidism. Elevated or low TSH in the context of
normal free thyroxine is often referred to as sub-clinical hypo- or hyperthyroidism respectively.
3. Both T4 & T3 provides limited clinical information as both are highly bound to proteins in circulation and reflects mostly inactive
hormone. Only a very small fraction of circulating hormone is free and biologically active.
4. Significant variations in TSH can occur with circadian rhythm, hormonal status, stress, sleep deprivation, medication &
circulating antibodies.
TSH T3 T4 FT4 Conditions
Primary Hypothyroidism, Post Thyroidectomy, Chronic Autoimmune
High Low Low Low
Thyroiditis
Subclinical Hypothyroidism, Autoimmune Thyroiditis, Insufficient Hormone
High N N N
Treatment.
N/Low Low Low Low Secondary and Tertiary Hypothyroidism
Primary Hyperthyroidism, Goitre, Thyroiditis, Drug effects, Early
Low High High High
Pregnancy
Low N N N Subclinical Hyperthyroidism
Low Low Low Low Central Hypothyroidism, Treatment with Hyperthyroidism
Low N High High Thyroiditis, Interfering Antibodies
N/Low High N N T3 Thyrotoxicosis, Non thyroidal causes
High High High High Pituitary Adenoma; TSHoma/Thyrotropinoma
Page 1 of 7
SIN No:SPL25034184
Patient Name : Mrs.SUJATHA V Collected : 01/Sep/2025 10:37AM
Age/Gender : 28 Y 11 M 13 D/F Received : 01/Sep/2025 11:16AM
UHID/MR No : RELE.0000001413 Reported : 01/Sep/2025 12:13PM
Visit ID : RELEOPV7811 Status : Final Report
Ref Doctor : Dr.Dr RITU CHOUDHARY
DEPARTMENT OF IMMUNOLOGY
Page 2 of 7
SIN No:SPL25034184
Patient Name : Mrs.SUJATHA V Collected : 01/Sep/2025 10:37AM
Age/Gender : 28 Y 11 M 13 D/F Received : 01/Sep/2025 01:26PM
UHID/MR No : RELE.0000001413 Reported : 01/Sep/2025 02:53PM
Visit ID : RELEOPV7811 Status : Final Report
Ref Doctor : Dr.Dr RITU CHOUDHARY
DEPARTMENT OF IMMUNOLOGY
Test Name Result Unit Bio. Ref. Interval Method
ANTI MULLERIAN HORMONE , SERUM 8.19 ng/mL 1.03-11.10 CLIA
Comment:
Antimullerian hormone (AMH), also known as mullerian-inhibiting substance is produced by Sertoli cells of the testis in males and by
ovarian granulosa cells in females.
In males, AMH serum concentrations are elevated under 2 years and then progressively decrease until puberty, when there is a sharp
decline.
In females, AMH is produced by the granulosa cells of small growing follicles from the 36th week of gestation onwards until menopause
when levels become undetectable.
Day to day variability of AMH concentration is low, hence AMH can be measured at any day during the menstrual cycle. However, it is
best to be measured on day 2-3.
AMH values are indicative of fertility potential.
Ovarian Fertility Potential AMH(ng/ml)
Optimal fertility 4.0 – 6.8
Satisfactory fertility 2.2 – 4.0
Low fertility 0.3 – 2.2
Very low/undetectable 0.0 – 0.3
High level 6.8or more
*The above interpretation is based on certain studies, and should be looked at in conjunction with the clinical details, antral follicle counts and other investigation findings.
The serum levels of AMH positively correlate with the basal antral follicle count that is measured by transvaginal USG. However, many
times discordance is seen between the AMH values and the AFC, as AMH represents pre-antral and small follicles, and AFC is based on
the follicles visualised during USG.
AMH values considered “normal” would also vary from age to age. Occasionally, both the normal women and those with diminished
reserve have overlapping low to undetectable AMH values.
Indications for monitoring AMH are:
Ovarian hyper stimulation syndrome- It is suggested in various studies that an AMH level >3.36 ng/mL was able to predict the development
of OHSS (sensitivity=90.5% and specificity=81.3%).
To diagnose and monitor women with PCOS.
It serves as a sensitive and specific marker for early detection of recurrence in patients with ovarian granulosa cell tumours.
In males, it is used to distinguish undescended testis, in which normal male AMH concentrations are seen, from anorchia, which have
extremely low or undetectable concentrations AMH levels.
To identify testicular dysgenesis, in which low concentrations of both AMH and testosterone are seen.
Page 3 of 7
SIN No:IM10414879
Patient Name : Mrs.SUJATHA V Collected : 01/Sep/2025 10:37AM
Age/Gender : 28 Y 11 M 13 D/F Received : 01/Sep/2025 01:26PM
UHID/MR No : RELE.0000001413 Reported : 01/Sep/2025 02:53PM
Visit ID : RELEOPV7811 Status : Final Report
Ref Doctor : Dr.Dr RITU CHOUDHARY
DEPARTMENT OF IMMUNOLOGY
In conjunction with FSH, LH and testosterone AMH is studied to diagnose precocious and delayed puberty.
Page 4 of 7
SIN No:IM10414879
Patient Name : Mrs.SUJATHA V Collected : 01/Sep/2025 10:37AM
Age/Gender : 28 Y 11 M 13 D/F Received : 01/Sep/2025 11:16AM
UHID/MR No : RELE.0000001413 Reported : 01/Sep/2025 12:13PM
Visit ID : RELEOPV7811 Status : Final Report
Ref Doctor : Dr.Dr RITU CHOUDHARY
DEPARTMENT OF IMMUNOLOGY
Test Name Result Unit Bio. Ref. Interval Method
FOLLICLE STIMULATING HORMONE 5.26 mIU/mL ECLIA
(FSH) , SERUM
Comment:
REFERENCE GROUP REFERENCE RANGE IN mIU/mL
FEMALES
* Follicular Phase 3.5 – 12.5
* Ovulation Phase 4.7 – 21.5
* Luteal Phase 1.7 – 7.7
* Post-menopause 25.8 – 134.8
MALES 1.5 – 12.4
Abnormal FSH levels are interpreted with increased or decreased levels of other fertility hormones such as LH, estrogens,
progesterone, and testosterone.
Increased FSH levels are associated with menopause and primary ovarian hypofunction in females and primary hypogonadism in
males.Decreased FSH levels are associated with primary ovarian hyperfunction in females and primary hypergonadism in males.
Normal or decreased FSH levels are associated with polycystic ovary disease in females.
Page 5 of 7
SIN No:SPL25034184
Patient Name : Mrs.SUJATHA V Collected : 01/Sep/2025 10:37AM
Age/Gender : 28 Y 11 M 13 D/F Received : 01/Sep/2025 11:16AM
UHID/MR No : RELE.0000001413 Reported : 01/Sep/2025 12:13PM
Visit ID : RELEOPV7811 Status : Final Report
Ref Doctor : Dr.Dr RITU CHOUDHARY
DEPARTMENT OF IMMUNOLOGY
Test Name Result Unit Bio. Ref. Interval Method
LH:LUTEINIZING HORMONE , SERUM 5.82 mIU/mL ECLIA
Comment:
REFERENCE GROUP REFERENCE RANGE IN mIU/mL
FEMALES
* Follicular Phase 2.4 – 12.6
* Ovulation Phase 14.0 – 95.6
* Luteal Phase 1.0 – 11.4
* Post-menopause 7.7 – 58.5
MALES 1.7 – 8.6
Abnormal LH levels are interpreted with increased or decreased levels of other fertility hormones such as FSH, estrogens,
progesterone, and testosterone.
Increased LH levels are associated primary ovarian hypogonadism and gonadotropin secreting pituitary tumors. Decreased LH
levels are associated with Hypothalamic GnRH deficiency, Pituitary LH deficiency, Ectopic steroid hormone production, GnRH
analog treatment.
Page 6 of 7
SIN No:SPL25034184
Patient Name : Mrs.SUJATHA V Collected : 01/Sep/2025 10:37AM
Age/Gender : 28 Y 11 M 13 D/F Received : 01/Sep/2025 11:16AM
UHID/MR No : RELE.0000001413 Reported : 01/Sep/2025 12:13PM
Visit ID : RELEOPV7811 Status : Final Report
Ref Doctor : Dr.Dr RITU CHOUDHARY
DEPARTMENT OF IMMUNOLOGY
Test Name Result Unit Bio. Ref. Interval Method
PROLACTIN , SERUM 21.48 ng/mL 4.79 - 23.3 ECLIA
Comment:
PROLACTIN:-
REFERENCE GROUP REFERENCE RANGE IN ng/mL
ADULT FEMALES
* PRE-MENOPAUSAL 3.3 – 26.7
* PREGNANCY 9.7 – 208.5
* POST MENOPAUSAL 2.7 – 19.6
MALES 2.6 – 13.1
Normal prolactin secretion varies with time, which results in serum prolactin levels two tothree times higher at night than during the
day.
Serum prolactin levels during the menstrual cycle are variable and commonly exhibit slight elevations during the mid-cycle. Prolactin
levels in normal individuals tend to rise in response to physiologic stimuli including sleep, exercise, nipple stimulation, sexual
intercourse, hypoglycemia, pregnancy, and surgical stress.
Prolactin values that exceed the reference values may be due to macroprolactin (prolactin bound to immunoglobulin).
Macroprolactin should be evaluated if signs and symptoms of hyperprolactinemia are absent or pituitary imaging studies are not
informative
*** End Of Report ***
Page 7 of 7
SIN No:SPL25034184
Patient Name : Mrs.SUJATHA V Collected : 01/Sep/2025 10:37AM
Age/Gender : 28 Y 11 M 13 D/F Received : 01/Sep/2025 11:16AM
UHID/MR No : RELE.0000001413 Reported : 01/Sep/2025 12:13PM
Visit ID : RELEOPV7811 Status : Final Report
Ref Doctor : Dr.Dr RITU CHOUDHARY
TERMS AND CONDITIONS GOVERNING THIS REPORT
1. Reported results are for information and interpretation of the referring doctor or such other medical professionals, who understand
reporting units, reference ranges and limitation of technologies. Laboratories not be responsible for any interpretation whatsoever
2. This is computer generated medical diagnostics report that has been validated by an Authorized Medical Practitioner/Doctor. The
report does not need physical signature.
3. Partial reproduction of this report is not valid and should not be resorted to draw any conclusion.
4. In the case you are not the intended recipient of this report. Please immediately return the same to the concerned issuing desk. Any
disclosure, copy or distribution of any contents of this report, is unlawful and is strictly prohibited.
5. Results delays may occur due to unforeseen circumstances such as non-availability of kits, equipment breakdown, natural calamities,
IT downtime, logistic delays or any other unavoidable event. For certain tests based on analyte stability, criticality of results and in the
interest of patient for having appropriate medical diagnosis, the same test may be outsourced to other accredited laboratory.
6. It is presumed that the tests performed are, on the specimen / sample being to the patient named or identified and the verifications of
particulars have been confirmed by the patient or his / her representative at the point of generation of said specimen
7. The reported results are restricted to the given specimen only. Results may vary from lab to lab and from time to time for the same
parameter for the same patient (within subject biological variation).
8. The patient details along with their results in certain cases like notifiable diseases and as per local regulatory requirements will be
communicated to the assigned regulatory bodies
9. The patient samples can be used as part of internal quality control, test verification, data analysis purposes within the testing scope of
the laboratory.
10. This report is not valid for medico legal purposes. It is performed to facilitate medical diagnosis only
SIN No:SPL25034184
